Preimplantation Genetic Testing Market

Market Overview:

The global preimplantation genetic testing market size reached US$ 527 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 883 Million by 2028, exhibiting a growth rate (CAGR) of 9.1% during 2023-2028.

Preimplantation genetic testing (PGT) identifies abnormal embryos and allows the transfer of genetically normal embryos. It reduces the trauma of multiple failed in vitro fertilization (IVF) cycles and early miscarriages. It also protects children from inherited monogenic disorders. As a result, it is used to treat individuals at high risk of having babies with specific genetic aberrations. It is also utilized in hematological disorders to cure the affected child and in cases of advanced maternal age to avoid the birth of a syndromic child. Nowadays, PGT technology is integrated with Assisted Reproductive Technology (ART) procedures to offer the best outcomes to patients around the world.

Preimplantation Genetic Testing Market Trends:

Chromosomal aneuploidies are one of the leading causes of infertility and maternal age-related reduced fertility. A significant rise in the birth rates and incidences of spontaneous miscarriages represents one of the key factors positively influencing the demand for PGT to reduce the need for multiple IVF cycles. In addition, as the risk of miscarriage grows gradually with the woman’s age, the emerging delayed parenthood trend is catalyzing the demand for PGT across the globe. Apart from this, the rising medical tourism and improving diagnostic modalities are other factors stimulating the market growth. Moreover, the introduction of novel techniques that include microarray and genome sequencing is propelling the market growth. Furthermore, with the discovery of deoxyribonucleic acid (DNA) within the blastocoele fluid (BF) of blastocysts and in spent embryo culture media (SCM), researchers are focusing on developing non-invasive methods of PGT. In confluence with this, the escalating demand for minimally invasive (MI) procedures is contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global preimplantation genetic testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, procedure, technology and application.

Breakup by Product:

• Reagents and Consumables
• Instruments
   

Breakup by Procedure:

• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis
   

Breakup by Technology:

• Next-Generation Sequencing
• Polymerase Chain Reaction
• Fluorescence in Situ Hybridization
• Comparative Genomic Hybridization
• Single-Nucleotide Polymorphism
   

Breakup by Application:

• Aneuploidy
• Single Gene Disorder
• Structural Chromosomal Abnormalities
  • Translocations
  • Deletions
  • Duplications
  • Inversions
• X-Linked Disorders
• Human Leukocyte Typing
• Gender Identification
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Oxford Gene Technology IP Limited (Sysmex Corporation), PerkinElmer Inc., Quest Diagnostics Incorporated, The Cooper Companies Inc and Thermo Fisher Scientific.

Report Coverage:

Key Questions Answered in This Report:

• How has the global preimplantation genetic testing market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global preimplantation genetic testing market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the procedure?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global preimplantation genetic testing market and who are the key players?
• What is the degree of competition in the industry?